Chronic fatigue syndrome: aetiology, diagnosis and treatment

Chronic fatigue syndrome is characterised by intense fatigue, with duration of over six months and associated to other related symptoms. The latter include asthenia and easily induced tiredness that is not recovered after a night's sleep. The fatigue becomes so severe that it forces a 50% reduction in daily activities. Given its unknown aetiology, different hypotheses have been considered to explain the origin of the condition (from immunological disorders to the presence of post-traumatic oxidative stress), although there are no conclusive diagnostic tests. Diagnosis is established through the exclusion of other diseases causing fatigue. This syndrome is rare in childhood and adolescence, although the fatigue symptom per se is quite common in paediatric patients. Currently, no curative treatment exists for patients with chronic fatigue syndrome. The therapeutic approach to this syndrome requires a combination of different therapeutic modalities. The specific characteristics of the symptomatology of patients with chronic fatigue require a rapid adaptation of the educational, healthcare and social systems to prevent the problems derived from current systems. Such patients require multidisciplinary management due to the multiple and different issues affecting them. This document was realized by one of the Interdisciplinary Work Groups from the Institute for Rare Diseases, and its aim is to point out the main social and care needs for people affected with Chronic Fatigue Syndrome. For this, it includes not only the view of representatives for different scientific societies, but also the patient associations view, because they know the true history of their social and sanitary needs. In an interdisciplinary approach, this work also reviews the principal scientific, medical, socio-sanitary and psychological aspects of Chronic Fatigue Syndrome.

[1]  A. Verbeek,et al.  Fatigue and chronic fatigue syndrome-like complaints in the general population. , 2010, European journal of public health.

[2]  G. Ricevuti,et al.  Immunological aspects of chronic fatigue syndrome. , 2009, Autoimmunity reviews.

[3]  Suzanne D Vernon,et al.  Cost Effectiveness and Resource Allocation Open Access the Economic Impact of Chronic Fatigue Syndrome , 2022 .

[4]  A. Fletcher,et al.  A Follow-up Study of Chronic Fatigue Syndrome in Children and Adolescents: Symptom Persistence and School Absenteeism , 2006, Clinical child psychology and psychiatry.

[5]  P. Whiting,et al.  The effectiveness of interventions used in the treatment/management of chronic fatigue syndrome and/or myalgic encephalomyelitis in adults and children , 2002 .

[6]  S. Wessely,et al.  The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. , 1997, American journal of public health.

[7]  M. Loveless,et al.  A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Hotopf,et al.  Epidemiology of chronic fatigue syndrome and self reported myalgic encephalomyelitis in 5-15 year olds: cross sectional study , 2003, BMJ : British Medical Journal.

[9]  M. Weiss,et al.  Psychiatric morbidity and illness experience of primary care patients with chronic fatigue in Hong Kong. , 2000, The American journal of psychiatry.

[10]  A. Rademaker,et al.  A community-based study of chronic fatigue syndrome. , 1999, Archives of internal medicine.

[11]  A. Komaroff,et al.  High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. , 1990, Arthritis and rheumatism.

[12]  L. Ridsdale,et al.  The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care , 2003, Psychological Medicine.

[13]  J R Morris,et al.  The Sickness Impact Profile: Conceptual Formulation and Methodology for the Development of a Health Status Measure , 1976, International journal of health services : planning, administration, evaluation.

[14]  R. Baker,et al.  Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance , 2007, BMJ : British Medical Journal.

[15]  D. Bell,et al.  Thirteen-year follow-up of children and adolescents with chronic fatigue syndrome. , 2001, Pediatrics.

[16]  D. Connell,et al.  Epidemiology of chronic fatigue syndrome: the Centers for Disease Control Study. , 2007, Ciba Foundation symposium.

[17]  A. Morton,et al.  Exercise prescription for individuals with chronic fatigue syndrome , 2005, The Medical journal of Australia.

[18]  P. Whiting,et al.  Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. , 2001, JAMA.

[19]  M. Smith.  Adolescent chronic fatigue syndrome. , 2004, Archives of pediatrics & adolescent medicine.

[20]  L. Leibovici,et al.  Primary fibromyalgia and the chronic fatigue syndrome , 2005, Rheumatology International.

[21]  E. Smets,et al.  The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. , 1995, Journal of psychosomatic research.

[22]  P. Tugwell,et al.  Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. , 1990, The Journal of rheumatology.

[23]  W. Reeves,et al.  Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome , 2005, Journal of autoimmune diseases.

[24]  M. Hotopf,et al.  Incidence, Prognosis, and Risk Factors for Fatigue and Chronic Fatigue Syndrome in Adolescents: A Prospective Community Study , 2007, Pediatrics.

[25]  R. Staud.  Treatment of fibromyalgia and its symptoms , 2007, Expert opinion on pharmacotherapy.

[26]  V. Hunot,et al.  Cognitive behaviour therapy for chronic fatigue syndrome in adults , 2022 .

[27]  P. Masand,et al.  Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants , 2009, Expert opinion on pharmacotherapy.

[28]  M. Sharpe.  Cognitive behavior therapy for functional somatic complaints. The example of chronic fatigue syndrome. , 1997, Psychosomatics.

[29]  H. Kuratsune.  [Overview of chronic fatigue syndrome focusing on prevalence and diagnostic criteria]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[30]  R. K. Price,et al.  Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. , 1992, Public health reports.

[31]  R. Larkins,et al.  Chronic fatigue syndrome clinical practice guidelines , 2002, The Medical journal of Australia.

[32]  M. Hotopf,et al.  A systematic review describing the prognosis of chronic fatigue syndrome. , 2005, Occupational medicine.

[33]  R. Vermeulen,et al.  Exploratory Open Label, Randomized Study of Acetyl- and Propionylcarnitine in Chronic Fatigue Syndrome , 2004, Psychosomatic medicine.

[34]  Rosane Nisenbaum,et al.  Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution , 2003, BMC health services research.

[35]  Matthew Hotopf,et al.  Chronic fatigue syndrome , 2010, BMJ : British Medical Journal.

[36]  M. I. Idiazábal Alecha,et al.  Diagnostic and treatment challenges of chronic fatigue syndrome: role of immediate-release methylphenidate , 2008, Expert review of neurotherapeutics.

[37]  Bhagat S Malhotra,et al.  Chronic Fatigue Syndrome: A Review , 2011 .

[38]  S. Wessely,et al.  A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. , 2003, Journal of psychosomatic research.

[39]  M. Smith,et al.  Comparative study of anxiety, depression, somatization, functional disability, and illness attribution in adolescents with chronic fatigue or migraine. , 2003, Pediatrics.

[40]  L. Yardley,et al.  Cognitive behavioural therapy and psycho-education for chronic fatigue syndrome in young people: reflections from the families' perspective. , 2010, British journal of health psychology.

[41]  I. Hickie,et al.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. , 1994, Annals of internal medicine.

[42]  J. Fries.  The assessment of disability: from first to future principles. , 1983, British journal of rheumatology.

[43]  A. Hackmann,et al.  Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial , 1996, BMJ.

[44]  P. Stallard,et al.  Anxiety in children with CFS/ME , 2009, European Child & Adolescent Psychiatry.

[45]  N. Iwata,et al.  Prevalence of chronic fatigue syndrome in a community population in Japan. , 1998, The Tohoku journal of experimental medicine.

[46]  Howard Amital,et al.  Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis. , 2008, The Israel Medical Association journal : IMAJ.